Results 21 to 30 of about 4,295 (215)

Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy.

PLoS ONE, 2014
BackgroundPalonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even though
Belen Sadaba, Anabel del Barrio, Miguel Angel Campanero, Jose Ramon Azanza, Almudena Gomez-Guiu, Jose Maria Lopez-Picazo, Salvador Martin Algarra, Francisco Guillén Grimá, Maria Blanco Prieto, Jose Luis Perez-Gracia, Alfonso Gurpide   +10 more
doaj   +1 more source

Comparison of palonosetron with ondansetron in prevention of postoperative nausea and vomiting in patients receiving intravenous patient-controlled analgesia after gynecological laparoscopic surgery [PDF]

Korean Journal of Anesthesiology, 2013
BackgroundPostoperative nausea and vomiting (PONV) are common complications after anesthesia and surgery. This study was designed to compare the effects of palonosetron and ondansetron in preventing PONV in high-risk patients receiving intravenous opioid-
Yu Yil Kim, Soo Yeong Moon, Dong Un Song, Ki Hyun Lee, Jae Wook Song, Young Eun Kwon   +5 more
doaj   +1 more source

Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy [PDF]

, 2010
In this update of our 2005 document, we used an evidence-based approach whenever possible to formulate recommendations, emphasizing the results of controlled trials concerning the best use of antiemetic agents for the prevention of emesis and nausea ...
Ballatori, Enzo, Bria, Emilio, Einhorn, Lawrence H, Espersen, Birgitte, Grunberg, Steven, Herrstedt, Jørn, Hesketh, Paul, Kris, Mark G, Morrow, Gary, Rittenberg, Cynthia, Saito, Mitsue, Tonato, Maurizio   +11 more
core   +1 more source

Efficacy of ondansetron and palonosetron in prevention of shivering under spinal anesthesia: A prospective randomized double-blind study in patients undergoing elective LSCS

Journal of Anaesthesiology Clinical Pharmacology, 2021
Background and Aims: Postanesthesia shivering (PAS) is a common, distressing experience. Ondansetron, the classical 5HT3 antagonist has been in use for its prevention since long.
Manoj K Sharma, Deepak Mishra, Nitin Goel   +2 more
doaj   +1 more source

Acute emesis: moderately emetogenic chemotherapy [PDF]

, 2010
This paper is a review of the recommendations for the prophylaxis of acute emesis induced by moderately emetogenic chemotherapy as concluded at the third Perugia Consensus Conference, which took place in June 2009.
Bria, Emilio, Herrstedt, Jørn, Hesketh, Paul J, Rapoport, Bernardo, Rittenberg, Cynthia, Roila, Fausto, Warr, David   +6 more
core   +1 more source

Randomised Control Study of Palonosetron Versus Dexamethasone in Preventing Postoperative Nausea and Vomiting Following Ear and Nose Surgeries under General Anesthesia [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: Postoperative Nausea and Vomiting (PONV) is defined as any nausea or vomiting that occurs during the first 48 hours after surgery. It is considered as a distressing event following anaesthesia.
Anju Annie Paul, Sagiev Koshy George, RV Ranjan, Mary Kurien, Athmanathan Mohan, Leenu Grace Ninan, Vinu Mervick Alfred   +6 more
doaj   +1 more source

Palonosetron [PDF]

pharma-kritik, 2008
Wie zum Beispiel Ondansetron wirkt Palonosetron gegen Brechreiz und Erbrechen im Zusammenhang mit emetogener Chemotherapie.
openaire   +1 more source

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: A Hoosier Cancer Research Network Study [PDF]

, 2016
Purpose A phase III study adding aprepitant to a 5HT3 receptor antagonist (5HT3-RA) plus dexamethasone in germ cell tumor (GCT) patients treated with 5-day cisplatin combination chemotherapy demonstrated a significant improvement in complete response (
Adra, Nabil, Albany, Costantine, Brames, Mary J., Breen, Timothy, Calley, Cynthia, Case-Eads, Somer, Einhorn, Lawrence H., Fausel, Christopher A., Hanna, Nasser H., Hauke, Ralph J., Liu, Ziyue, Picus, Joel   +11 more
core   +2 more sources

Comparison of efficacy of palonosetron-dexamethasone combination with palonosetron or dexamethasone alone for prophylaxis against post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy

Indian Journal of Anaesthesia, 2017
Background and Aims: Post-operative nausea and vomiting (PONV) is highly distressing and unpleasant symptom. Dexamethasone and palonosetron are effective antiemetics with minimal side effect profile.
Arindam Chatterjee, Sandeep Sahu, Mekhala Paul, Tanya Singh, Surendra Singh, Prabhaker Mishra   +5 more
doaj   +1 more source

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting [PDF]

, 2016
BACKGROUND We examined the efficacy of olanzapine for the prevention of nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Bajaj, Madhuri, Biggs, David, Dietrich, Leah, Lafky, Jacqueline M., Liu, Heshan, Loprinzi, Charles L., Navari, Rudolph M., Powell, Steven F., Qin, Rui, Ruddy, Kathryn J.   +9 more
core   +1 more source